Catalyst Pharmaceuticals Inc (CPRX)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 851,411 | 470,114 | 375,630 | 237,788 | 192,354 |
| Total stockholders’ equity | US$ in thousands | 727,632 | 387,881 | 300,421 | 206,831 | 169,598 |
| Financial leverage ratio | 1.17 | 1.21 | 1.25 | 1.15 | 1.13 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $851,411K ÷ $727,632K
= 1.17
The financial leverage ratio of Catalyst Pharmaceuticals Inc has been fluctuating over the past five years. It increased from 1.13 in December 2020 to 1.15 in December 2021, indicating a slight rise in the company's reliance on debt to finance its operations. Subsequently, there was a significant jump to 1.25 in December 2022, suggesting a higher level of debt utilization. However, the ratio decreased to 1.21 in December 2023 and further dropped to 1.17 in December 2024. These declines may indicate a slight decrease in the company's financial risk and a move towards a more conservative debt structure in the later years. Overall, while the ratio experienced fluctuations, it remained relatively close to the range of 1, indicating a balanced mix of debt and equity in the company's capital structure.
Peer comparison
Dec 31, 2024